ROYAL BANK OF CANADA - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$0324
+1017.2%
0.00%
Q1 2023$029
-90.2%
0.00%
Q3 2022$0
-100.0%
296
-88.2%
0.00%
Q3 2021$10,000
-44.4%
2,500
-53.7%
0.00%
Q2 2021$18,000
+157.1%
5,397
+60.4%
0.00%
Q1 2021$7,000
-12.5%
3,364
-6.0%
0.00%
Q4 2020$8,000
+300.0%
3,580
+320.2%
0.00%
Q3 2020$2,000
-50.0%
852
-28.2%
0.00%
Q2 2020$4,000
-83.3%
1,186
-90.1%
0.00%
Q1 2020$24,000
+700.0%
12,012
+865.6%
0.00%
Q4 2019$3,000
-40.0%
1,244
-11.8%
0.00%
Q3 2019$5,0000.0%1,410
+28.2%
0.00%
Q2 2019$5,000
-16.7%
1,1000.0%0.00%
Q1 2019$6,000
+50.0%
1,1000.0%0.00%
Q4 2018$4,000
-77.8%
1,100
-62.4%
0.00%
Q3 2018$18,000
+80.0%
2,925
+82.8%
0.00%
Q2 2018$10,000
+233.3%
1,600
+166.7%
0.00%
Q1 2018$3,000
+50.0%
600
-13.3%
0.00%
Q4 2017$2,000692
+2561.5%
0.00%
Q3 2017$026
+766.7%
0.00%
Q2 2017$03
-98.2%
0.00%
Q4 2016$0167
+247.9%
0.00%
Q2 2016$048
-81.2%
0.00%
Q4 2015$0255
-39.6%
0.00%
Q3 2015$0422
+58.1%
0.00%
Q2 2015$0267
+167.0%
0.00%
Q1 2015$01000.0%0.00%
Q4 2014$0
-100.0%
1000.0%0.00%
Q3 2014$1,0000.0%1000.0%0.00%
Q2 2014$1,000
-50.0%
1000.0%0.00%
Q1 2014$2,000
+100.0%
100
-10.7%
0.00%
Q4 2013$1,0000.0%112
+12.0%
0.00%
Q3 2013$1,0000.0%100
-60.0%
0.00%
Q2 2013$1,0002500.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders